Rac’n’rolling the immune system
In this issue of Blood, Donkó et al report the clinical and biological features of a unique cohort of 54 patients from 37 families with Ras-related C3 botu
In this issue of Blood, Donkó et al report the clinical and biological features of a unique cohort of 54 patients from 37 families with Ras-related C3 botu
This secondary analysis of a randomized clinical trial examines 5-year outcomes of laparoscopic total gastrectomy with laparoscopic spleen-preserving splenic hilar lymphadenectomy vs laparoscopic total gastrectomy…
A huge global inequality related to cancer is the difference in overall survival of children with cancer in low-income and middle-income countries (LMICs; survival rates…
Regular mammograms to screen for breast cancer should start younger — at age 40. The U.S. Preventive Services Task Force announced the updated guidance Tuesday.
Biennial screening mammography is recommended for those who are 40 to 74 years old rather than individualizing screening decisions in this age group.
A systematic review and meta-analysis found that neoadjuvant chemoimmunotherapy was associated with improved event-free survival and pathologic complete response compared with neoadjuvant chemotherapy…
Frontline pembrolizumab plus trastuzumab/chemotherapy improved overall survival in HER2-positive, unresectable or metastatic gastric/GEJ cancer.
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Treatment with EVT801 was well tolerated and led to a stable disease rate of 46% in patients with advanced ovarian cancer.
Summary:. Spatial biology approaches enabled by innovations in imaging biomarker platforms and artificial intelligence–enabled data integration and analysis provide an assessment of patient and disease…
SLS009 plus venetoclax and azacitidine elicited responses in patients with relapsed/refractory AML, particularly in those harboring ASXL1 mutations.